Certified by Founder
Lodge
Baseimmune
start up
United Kingdom
- London, England
- 29/02/2024
- Series A
- $11,402,055
Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
- Industry Biotechnology Research
- Website https://www.baseimmune.co.uk/
- LinkedIn https://www.linkedin.com/company/baseimmune/
Related People
Joshua BlightCo Founder
United Kingdom -
ND
Research scientist and biotech co-founder specialising in infectious diseases with a particular interest in mosquito-borne diseases. Skilled in Bioinformatics, Cell Biology, Vaccinology, Immunology, Parasitology and Molecular Biology. Additional experience in Science Communication, Public Engagement and Graphic Design. DPhil in Clinical Medicine, Oxford.
Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
IORGANBIO | $2,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)